Big tick for me was the original and subsequent agreements for Cannvalate to cover the cost of the 4 clinical trials up to Phase2a.
So even though TMJ trial has been put in on the back burner and OSA moved into a Phase2b straight away.
This was a genius move by the BOD to reduce the need for short term funding of expensive trials while the share price was low.
Friday was an exciting day over there.
Big tick for me was the original and subsequent agreements for...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.744M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500099 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 24000 | 1 |
View Market Depth
| Last trade - 16.12pm 28/06/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable